The gut microbiota contributes to host energy metabolism, and altered gut microbiota has been associated with obesity-related metabolic disorders. We previously reported that a probiotic alone or together with a prebiotic controls body fat mass in healthy overweight or obese individuals in a randomised, double-blind, placebo controlled clinical study (ClinicalTrials.gov NCT01978691). We now aimed to investigate whether changes in the gut microbiota may be associated with the observed clinical benefits. Faecal and plasma samples were obtained from a protocol compliant subset (n=134) of participants from a larger clinical study where participants were randomised (1:1:1:1) into four groups: (1) placebo, 12 g/d microcrystalline cellulose; (2) Litesse® Ultra™ polydextrose (LU), 12 g/day; (3) Bifidobacterium animalis subsp. lactis 420™ (B420), 1010 cfu/d in 12 g microcrystalline cellulose; (4) LU+B420, 1010 cfu/d of B420 in 12 g/d LU for 6 months of intervention. The faecal microbiota composition and metabolites were assessed as exploratory outcomes at baseline, 2, 4, 6 months, and +1 month post-intervention and correlated to obesity-related clinical outcomes. Lactobacillus and Akkermansia were more abundant with B420 at the end of the intervention. LU+B420 increased Akkermansia, Christensenellaceae and Methanobrevibacter, while Paraprevotella was reduced. Christensenellaceae was consistently increased in the LU and LU+B420 groups across the intervention time points, and correlated negatively to waist-hip ratio and energy intake at baseline, and waist-area body fat mass after 6 months treatment with LU+B420. Functional metagenome predictions indicated alterations in pathways related to cellular processes and metabolism. Plasma bile acids glycocholic acid, glycoursodeoxycholic acid, and taurohyodeoxycholic acid and tauroursodeoxycholic acid were reduced in LU+B420 compared to Placebo. Consumption of B420 and its combination with LU resulted in alterations of the gut microbiota and its metabolism, and may support improved gut barrier function and obesity-related markers.
Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez-Humaran, L.G., Smirnova, N., Berge, M., Sulpice, T., Lahtinen, S., Ouwehand, A., Langella, P., Rautonen, N., Sansonetti, P.J. and Burcelin, R., 2011. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 3: 559-572.
'Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment ' () 3 EMBO Molecular Medicine : 559 -572.
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., Hattori, M. and Koga, Y., 2017. A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation. Science Reports 7: 43522.
'A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation ' () 7 Science Reports : 43522.
Aronesty, E., 2011. ea-utils: Command-line tools for processing biological sequencing data. Available online at: http://tinyurl.com/y9bn5rkc.
Brahe, L.K., Le Chatelier, E., Prifti, E., Pons, N., Kennedy, S., Hansen, T., Pedersen, O., Astrup, A., Ehrlich, S.D. and Larsen, L.H., 2015. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutrition and Diabetes 5: e159.
'Specific gut microbiota features and metabolic markers in postmenopausal women with obesity ' () 5 Nutrition and Diabetes : e159.
Cani, P.D., Geurts, L., Matamoros, S., Plovier, H. and Duparc, T., 2014. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond. Diabetes and Metabolism 40: 246-257.
'Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond ' () 40 Diabetes and Metabolism : 246 -257.
Caporaso, J.G., Bittinger, K., Bushman, F.D., DeSantis, T.Z., Andersen, G.L. and Knight, R., 2010a. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 26: 266-267.
'PyNAST: a flexible tool for aligning sequences to a template alignment ' () 26 Bioinformatics : 266 -267.
Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., McDonald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Turnbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J. and Knight, R., 2010b. QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7: 335-336.
'QIIME allows analysis of high-throughput community sequencing data ' () 7 Nature Methods : 335 -336.
Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S.M., Betley, J., Fraser, L., Bauer, M., Gormley, N., Gilbert, J.A., Smith, G. and Knight, R., 2012. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME Journal 6: 1621-1624.
'Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms ' () 6 ISME Journal : 1621 -1624.
Cavalcante-Silva, L.H., Galvao, J.G., Da Silva, J.S., De Sales-Neto, J.M. and Rodrigues-Mascarenhas, S., 2015. Obesity-driven gut microbiota inflammatory pathways to metabolic syndrome. Frontiers in Physiology 6: 341.
'Obesity-driven gut microbiota inflammatory pathways to metabolic syndrome ' () 6 Frontiers in Physiology : 341.
Costabile, A., Fava, F., Roytio, H., Forssten, S.D., Olli, K., Klievink, J., Rowland, I.R., Ouwehand, A.C., Rastall, R.A., Gibson, G.R. and Walton, G.E., 2012. Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects. British Journal of Nutrition 108: 471-481.
'Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects ' () 108 British Journal of Nutrition : 471 -481.
Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., Gougis, S., Rizkalla, S., Batto, J.M., Renault, P., Dore, J., Zucker, J.D., Clement, K. and Ehrlich, S.D., 2013. Dietary intervention impact on gut microbial gene richness. Nature 500: 585-588.
'Dietary intervention impact on gut microbial gene richness ' () 500 Nature : 585 -588.
Crovesy, L., Ostrowski, M., Ferreira, D., Rosado, E.L. and Soares-Mota, M., 2017. Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials. International Journal of Obesity 41: 1607-1614.
'Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials ' () 41 International Journal of Obesity : 1607 -1614.
Danilo, C.A., Constantopoulos, E., McKee, L.A., Chen, H., Regan, J.A., Lipovka, Y., Lahtinen, S., Stenman, L.K., Nguyen, T.V., Doyle, K.P., Slepian, M.J., Khalpey, Z.I. and Konhilas, J.P., 2017. Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse. Beneficial Microbes 8: 257-269.
'Bifidobacterium animalis subsp ' () 8 Beneficial Microbes : 257 -269.
Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., Kayser, B.D., Levenez, F., Chilloux, J., Hoyles, L., Dumas, M.E., Rizkalla, S.W., Dore, J., Cani, P.D. and Clement, K., 2016. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65: 426-436.
'Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology ' () 65 Gut : 426 -436.
DeSantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Huber, T., Dalevi, D., Hu, P. and Andersen, G.L., 2006. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied and Environmental Microbiology 72: 5069-5072.
'Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB ' () 72 Applied and Environmental Microbiology : 5069 -5072.
Edgar, R.C., 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460-2461.
'Search and clustering orders of magnitude faster than BLAST ' () 26 Bioinformatics : 2460 -2461.
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., De Vos, W.M. and Cani, P.D., 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the USA 110: 9066-9071.
'Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity ' () 110 Proceedings of the National Academy of Sciences of the USA : 9066 -9071.
Faith, D.P., 1992. Conservation evaluation and phylogenetic diversity. Biological Conservation 61: 1-10.
'Conservation evaluation and phylogenetic diversity ' () 61 Biological Conservation : 1 -10.
Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Scott, K., Stanton, C., Swanson, K.S., Cani, P.D., Verbeke, K. and Reid, G., 2017. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology and Hepatology 14: 491-502.
'Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics ' () 14 Nature Reviews Gastroenterology and Hepatology : 491 -502.
Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J.T., Spector, T.D., Clark, A.G. and Ley, R.E., 2014. Human genetics shape the gut microbiome. Cell 159: 789-799.
'Human genetics shape the gut microbiome ' () 159 Cell : 789 -799.
Han, J., Liu, Y., Wang, R., Yang, J., Ling, V. and Borchers, C.H., 2015. Metabolic profiling of bile acids in human and mouse blood by LC-MS/MS in combination with phospholipid-depletion solid-phase extraction. Analytical Chemistry 87: 1127-1136.
'Metabolic profiling of bile acids in human and mouse blood by LC-MS/MS in combination with phospholipid-depletion solid-phase extraction ' () 87 Analytical Chemistry : 1127 -1136.
Hao, J., Liebeke, M., Astle, W., De Iorio, M., Bundy, J.G. and Ebbels, T.M., 2014. Bayesian deconvolution and quantification of metabolites in complex 1D NMR spectra using BATMAN. Nature Protocols 9: 1416-1427.
'Bayesian deconvolution and quantification of metabolites in complex 1D NMR spectra using BATMAN ' () 9 Nature Protocols : 1416 -1427.
Heimann, E., Nyman, M., Palbrink, A.K., Lindkvist-Petersson, K. and Degerman, E., 2016. Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes. Adipocyte 5: 359-368.
'Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes ' () 5 Adipocyte : 359 -368.
Holscher, H.D., Caporaso, J.G., Hooda, S., Brulc, J.M., Fahey Jr., G.C. and Swanson, K.S., 2015. Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial. American Journal of Clinical Nutrition 101: 55-64.
'Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial ' () 101 American Journal of Clinical Nutrition : 55 -64.
Hooda, S., Boler, B.M., Serao, M.C., Brulc, J.M., Staeger, M.A., Boileau, T.W., Dowd, S.E., Fahey Jr., G.C. and Swanson, K.S., 2012. 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. Journal of Nutrition 142: 1259-1265.
'454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber ' () 142 Journal of Nutrition : 1259 -1265.
Jie, Z., Bang-Yao, L., Ming-Jie, X., Hai-Wei, L., Zu-Kang, Z., Ting-Song, W. and Craig, S.A., 2000. Studies on the effects of polydextrose intake on physiologic functions in Chinese people. American Journal of Clinical Nutrition 72: 1503-1509.
'Studies on the effects of polydextrose intake on physiologic functions in Chinese people ' () 72 American Journal of Clinical Nutrition : 1503 -1509.
Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M. and Tsuchida, T., 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 64: 636-643.
'Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial ' () 64 European Journal of Clinical Nutrition : 636 -643.
Lamichhane, S., Yde, C.C., Forssten, S., Ouwehand, A.C., Saarinen, M., Jensen, H.M., Gibson, G.R., Rastall, R., Fava, F. and Bertram, H.C., 2014. Impact of dietary polydextrose fiber on the human gut metabolome. Journal of Agricultural and Food Chemistry 62: 9944-9951.
'Impact of dietary polydextrose fiber on the human gut metabolome ' () 62 Journal of Agricultural and Food Chemistry : 9944 -9951.
Lamichhane, S., Yde, C.C., Schmedes, M.S., Jensen, H.M., Meier, S. and Bertram, H.C., 2015. Strategy for nuclear-magnetic-resonance-based metabolomics of human feces. Analytical Chemistry 87: 5930-5937.
'Strategy for nuclear-magnetic-resonance-based metabolomics of human feces ' () 87 Analytical Chemistry : 5930 -5937.
Langille, M.G., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Clemente, J.C., Burkepile, D.E., Vega Thurber, R.L., Knight, R., Beiko, R.G. and Huttenhower, C., 2013. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature Biotechnology 31: 814-821.
'Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences ' () 31 Nature Biotechnology : 814 -821.
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jorgensen, T., Brandslund, I., Nielsen, H.B., Juncker, A.S., Bertalan, M., Levenez, F., Pons, N., Rasmussen, S., Sunagawa, S., Tap, J., Tims, S., Zoetendal, E.G. Brunak, S., Clement, K., Dore, J., Kleerebezem, M., Kristiansen, K., Renault, P., Sicheritz-Ponten, T., De Vos, W.M., Zucker, J.D., Raes, J., Hansen, T., Bork, P., Wang, J., Ehrlich, S.D. and Pedersen, O., 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546.
'Richness of human gut microbiome correlates with metabolic markers ' () 500 Nature : 541 -546.
Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I., 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
'Microbial ecology: human gut microbes associated with obesity ' () 444 Nature : 1022 -1023.
Louis, S., Tappu, R.M., Damms-Machado, A., Huson, D.H. and Bischoff, S.C., 2016. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLoS ONE 11: e0149564.
'Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing ' () 11 PLoS ONE : e0149564.
Lozupone, C. and Knight, R., 2005. UniFrac: a new phylogenetic method for comparing microbial communities. Applied and Environmental Microbiology 71: 8228-8235.
'UniFrac: a new phylogenetic method for comparing microbial communities ' () 71 Applied and Environmental Microbiology : 8228 -8235.
McDonald, D., Price, M.N., Goodrich, J., Nawrocki, E.P., DeSantis, T.Z., Probst, A., Andersen, G.L., Knight, R. and Hugenholtz, P., 2012. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME Journal 6: 610-618.
'An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea ' () 6 ISME Journal : 610 -618.
Modica, S., Gadaleta, R.M. and Moschetta, A., 2010. Deciphering the nuclear bile acid receptor FXR paradigm. Nuclear Receptor Signaling 8: e005.
'Deciphering the nuclear bile acid receptor FXR paradigm ' () 8 Nuclear Receptor Signaling : e005.
Mukerji, P., Roper, J.M., Stahl, B., Smith, A.B., Burns, F., Rae, J.C., Yeung, N., Lyra, A., Svard, L., Saarinen, M.T., Alhoniemi, E., Ibarra, A. and Ouwehand, A.C., 2016. Safety evaluation of AB-LIFE((R)) (Lactobacillus plantarum CECT 7527, 7528 and 7529): antibiotic resistance and 90-day repeated-dose study in rats. Food and Chemical Toxicology 92: 117-128.
'Safety evaluation of AB-LIFE((R)) (Lactobacillus plantarum CECT 7527, 7528 and 7529): antibiotic resistance and 90-day repeated-dose study in rats ' () 92 Food and Chemical Toxicology : 117 -128.
Nagata, S., Chiba, Y., Wang, C. and Yamashiro, Y., 2017. The effects of the Lactobacillus casei strain on obesity in children: a pilot study. Beneficial Microbes 8: 535-543.
'The effects of the Lactobacillus casei strain on obesity in children: a pilot study ' () 8 Beneficial Microbes : 535 -543.
Ouwehand, A.C., Isolauri, E., Kirjavainen, P.V. and Salminen, S.J., 1999. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiology Letters 172: 61-64.
'Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups ' () 172 FEMS Microbiology Letters : 61 -64.
Pekkala, S., Munukka, E., Kong, L., Pollanen, E., Autio, R., Roos, C., Wiklund, P., Fischer-Posovszky, P., Wabitsch, M., Alen, M., Huovinen, P. and Cheng, S., 2015. Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation. Obesity 23: 581-590.
'Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation ' () 23 Obesity : 581 -590.
Price, M.N., Dehal, P.S. and Arkin, A.P., 2010. FastTree 2 – approximately maximum-likelihood trees for large alignments. PLoS ONE 5: e9490.
'FastTree 2 – approximately maximum-likelihood trees for large alignments ' () 5 PLoS ONE : e9490.
Putaala, H., Barrangou, R., Leyer, G.J., Ouwehand, A.C., Hansen, E.B., Romero, D.A. and Rautonen, N., 2010. Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli. Beneficial Microbes 1: 283-295.
'Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli ' () 1 Beneficial Microbes : 283 -295.
Putaala, H., Salusjarvi, T., Nordstrom, M., Saarinen, M., Ouwehand, A.C., Bech Hansen, E. and Rautonen, N., 2008. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Research in Microbiology 159: 692-698.
'Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression ' () 159 Research in Microbiology : 692 -698.
R Development Core Team, 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
Shih, D.M., Shaposhnik, Z., Meng, Y., Rosales, M., Wang, X., Wu, J., Ratiner, B., Zadini, F., Zadini, G. and Lusis, A.J., 2013. Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice. FASEB Journal 27: 3805-3817.
'Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice ' () 27 FASEB Journal : 3805 -3817.
Stenman, L.K., Burcelin, R. and Lahtinen, S., 2016a. Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans – towards treatment with probiotics. Beneficial Microbes 7: 11-22.
'Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans – towards treatment with probiotics ' () 7 Beneficial Microbes : 11 -22.
Stenman, L.K., Lehtinen, M.J., Meland, N., Christensen, J.E., Yeung, N., Saarinen, M.T., Courtney, M., Burcelin, R., Lahdeaho, M.L., Linros, J., Apter, D., Scheinin, M., Kloster Smerud, H., Rissanen, A. and Lahtinen, S., 2016b. Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults-randomized controlled trial. EBioMedicine 13: 190-200.
'Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults-randomized controlled trial ' () 13 EBioMedicine : 190 -200.
Stenman, L.K., Waget, A., Garret, C., Klopp, P., Burcelin, R. and Lahtinen, S., 2014. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Beneficial Microbes 5: 437-445.
'Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice ' () 5 Beneficial Microbes : 437 -445.
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
'An obesity-associated gut microbiome with increased capacity for energy harvest ' () 444 Nature : 1027 -1031.
Upadhyaya, B., McCormack, L., Fardin-Kia, A.R., Juenemann, R., Nichenametla, S., Clapper, J., Specker, B. and Dey, M., 2016. Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions. Science Reports 6: 28797.
'Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions ' () 6 Science Reports : 28797.
Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., Sitaraman, S.V., Knight, R., Ley, R.E. and Gewirtz, A.T., 2010. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328: 228-231.
'Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5 ' () 328 Science : 228 -231.
Warnes, G.R., Bolker, B., Bonebakker, L., Gentleman, R., Liaw, W.H.A., Lumley, T., Maechler, M., Magnusson, A., Moeller, S., Schwartz, S. and Venables, B., 2012. gplots: various R programming tools for plotting data. Available at: http://CRAN.R-project.org/package=gplots.
World Health Organisation (WHO), 2016. Obesity and overweight. Available at: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
Wickham, H., 2009. ggplot2: elegant graphics for data analysis. Springer-Verlag, New York, NY, USA.
'ggplot2: elegant graphics for data analysis', ().
Zhernakova, A., Kurilshikov, A., Bonder, M.J., Tigchelaar, E.F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A.V., Falony, G., Vieira-Silva, S., Wang, J., Imhann, F., Brandsma, E., Jankipersadsing, S.A., Joossens, M., Cenit, M.C., Deelen, P., Swertz, M.A., Weersma, R.K., Feskens, E.J., Netea, M.G., Gevers, D., Jonkers, D., Franke, L., Aulchenko, Y.S., Huttenhower, C., Raes, J., Hofker, M.H., Xavier, R.J., Wijmenga, C. and Fu, J., 2016. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352: 565-569.
'Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity ' () 352 Science : 565 -569.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 1047 | 1042 | 211 |
PDF Views & Downloads | 1173 | 1168 | 245 |
The gut microbiota contributes to host energy metabolism, and altered gut microbiota has been associated with obesity-related metabolic disorders. We previously reported that a probiotic alone or together with a prebiotic controls body fat mass in healthy overweight or obese individuals in a randomised, double-blind, placebo controlled clinical study (ClinicalTrials.gov NCT01978691). We now aimed to investigate whether changes in the gut microbiota may be associated with the observed clinical benefits. Faecal and plasma samples were obtained from a protocol compliant subset (n=134) of participants from a larger clinical study where participants were randomised (1:1:1:1) into four groups: (1) placebo, 12 g/d microcrystalline cellulose; (2) Litesse® Ultra™ polydextrose (LU), 12 g/day; (3) Bifidobacterium animalis subsp. lactis 420™ (B420), 1010 cfu/d in 12 g microcrystalline cellulose; (4) LU+B420, 1010 cfu/d of B420 in 12 g/d LU for 6 months of intervention. The faecal microbiota composition and metabolites were assessed as exploratory outcomes at baseline, 2, 4, 6 months, and +1 month post-intervention and correlated to obesity-related clinical outcomes. Lactobacillus and Akkermansia were more abundant with B420 at the end of the intervention. LU+B420 increased Akkermansia, Christensenellaceae and Methanobrevibacter, while Paraprevotella was reduced. Christensenellaceae was consistently increased in the LU and LU+B420 groups across the intervention time points, and correlated negatively to waist-hip ratio and energy intake at baseline, and waist-area body fat mass after 6 months treatment with LU+B420. Functional metagenome predictions indicated alterations in pathways related to cellular processes and metabolism. Plasma bile acids glycocholic acid, glycoursodeoxycholic acid, and taurohyodeoxycholic acid and tauroursodeoxycholic acid were reduced in LU+B420 compared to Placebo. Consumption of B420 and its combination with LU resulted in alterations of the gut microbiota and its metabolism, and may support improved gut barrier function and obesity-related markers.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 1047 | 1042 | 211 |
PDF Views & Downloads | 1173 | 1168 | 245 |